drugset / Trial / NCT03608241
A STUDY TO ESTIMATE THE EFFECT OF PF-06651600 ON THE PHARMACOKINETICS (PK) OF ORAL CONTRACEPTIVE (OC)
RandomizedCrossoverOpen-labelBasic science
Summary
This is a Phase 1, randomized, 2 way crossover, multiple dose, open label study of the effect of multiple dose PF-06651600 on single dose OC PK in healthy female subjects. Subjects will be randomized to 1 of 2 treatment sequences.
Timeline
- Start
- 2018-09-21
- Primary completion
- 2018-11-23
- Completion
- 2018-11-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritlecitinib | Small molecule | 200 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 30 ug | Oral |
| Subject | levonogestrel | Unknown | 150 ug | Oral |
Indications
No indication recorded.